---
created: '2026-02-09T05:54:32.703557Z'
description: The cellular degradation and recycling system that removes damaged organelles
  and protein aggregates. Dysfunction contributes to accumulation of toxic proteins
  in neurodegenerative diseases.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/pathway/autophagy-lysosomal-pathway/
slug: autophagy-lysosomal-pathway
tags:
- pathway
- neurodegeneration
- autophagy
- lysosome
- proteostasis
templateEngineOverride: njk
title: Autophagy-Lysosomal Pathway
type: pathway
updated: '2026-02-09T05:54:32.703557Z'
---

{% raw %}
<h1>Autophagy-Lysosomal Pathway</h1>
<h2>Overview</h2>
<p>The autophagy-lysosomal pathway (ALP) is the primary cellular system for degrading and recycling long-lived proteins, protein aggregates, and damaged organelles. Autophagy (&quot;self-eating&quot;) delivers cargo to lysosomes for breakdown. In neurons, which are post-mitotic and cannot dilute toxic proteins through cell division, a functional ALP is critical for survival. Dysfunction of this pathway is implicated in virtually all neurodegenerative diseases.</p>
<h2>Types of Autophagy</h2>
<h3>Macroautophagy</h3>
<ul>
<li>Most studied form</li>
<li>Double-membrane vesicles (autophagosomes) engulf cargo</li>
<li>Autophagosomes fuse with lysosomes</li>
<li>Bulk degradation</li>
</ul>
<h3>Chaperone-Mediated Autophagy (CMA)</h3>
<ul>
<li>Selective degradation via KFFERQ-like motifs</li>
<li>HSC70 recognizes substrates</li>
<li>LAMP2A receptor on lysosome</li>
<li>Direct translocation into lysosome</li>
</ul>
<h3>Microautophagy</h3>
<ul>
<li>Direct invagination of lysosomal membrane</li>
<li>Less characterized in neurons</li>
</ul>
<h2>Macroautophagy Steps</h2>
<h3>1. Initiation</h3>
<ul>
<li><strong>ULK1 complex</strong>: Senses nutrient/energy status</li>
<li>mTORC1 inhibition activates autophagy</li>
<li>AMPK activation promotes autophagy</li>
</ul>
<h3>2. Nucleation</h3>
<ul>
<li><strong>Beclin-1 complex</strong>: VPS34, ATG14</li>
<li>PI3P production</li>
<li>Omegasome formation</li>
</ul>
<h3>3. Elongation</h3>
<ul>
<li><strong>ATG5-ATG12-ATG16L complex</strong></li>
<li><strong>LC3-II</strong>: Lipidated LC3 marks autophagosome membrane</li>
<li>Membrane expansion</li>
</ul>
<h3>4. Cargo Recognition</h3>
<ul>
<li><strong>p62/SQSTM1</strong>: Ubiquitin-binding adaptor</li>
<li><strong>OPTN, NBR1, NDP52</strong>: Additional adaptors</li>
<li>Selective autophagy of aggregates (aggrephagy)</li>
</ul>
<h3>5. Fusion</h3>
<ul>
<li>Autophagosome-lysosome fusion</li>
<li>SNARE proteins, Rab7</li>
<li>Autolysosome formation</li>
</ul>
<h3>6. Degradation</h3>
<ul>
<li>Lysosomal hydrolases (cathepsins)</li>
<li>Acidic pH (~4.5)</li>
<li>Nutrient recycling</li>
</ul>
<h2>Regulation</h2>
<h3>Inhibitors of Autophagy</h3>
<ul>
<li><strong>mTORC1</strong>: Master negative regulator</li>
<li>Fed state, growth factors</li>
<li>High amino acids</li>
</ul>
<h3>Activators of Autophagy</h3>
<ul>
<li><strong>AMPK</strong>: Energy sensor; activates autophagy</li>
<li>Starvation, caloric restriction</li>
<li>Exercise</li>
<li>Rapamycin (mTOR inhibitor)</li>
<li>Spermidine, resveratrol</li>
</ul>
<h2>Dysfunction in Disease</h2>
<h3>Alzheimer's Disease</h3>
<ul>
<li>Autophagosome accumulation</li>
<li>Lysosomal acidification defects (presenilin)</li>
<li>APOE4 impairs autophagy</li>
<li>Aβ and tau accumulate</li>
</ul>
<h3>Parkinson's Disease</h3>
<ul>
<li>PINK1/Parkin mitophagy defects</li>
<li>α-synuclein impairs autophagy</li>
<li>GBA1 mutations → lysosomal dysfunction</li>
<li>LRRK2 affects autophagy</li>
</ul>
<h3>Huntington's Disease</h3>
<ul>
<li>Mutant huntingtin impairs cargo recognition</li>
<li>p62 dysfunction</li>
<li>Autophagosome formation defects</li>
</ul>
<h3>ALS</h3>
<ul>
<li>TDP-43, FUS, C9orf72 affect autophagy</li>
<li>Stress granule accumulation</li>
<li>Autophagy receptor mutations</li>
</ul>
<h3>Lysosomal Storage Disorders</h3>
<ul>
<li>Enzyme deficiencies</li>
<li>Substrate accumulation</li>
<li>Secondary autophagy block</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ [[Parkinsons_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Cascade]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Ubiquitin-Proteasome_System]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Intermittent_Fasting]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Huntingtons_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[mTOR_Signaling]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Tau_Phosphorylation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_Aggregation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Caloric_Restriction]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Frontotemporal_Dementia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyotrophic_Lateral_Sclerosis]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:40.063840'
source: obsidian
</code></pre>
<ul>
<li>→ [[Tau_Phosphorylation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[AMPK]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[mTOR_Signaling]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Ubiquitin-Proteasome_System]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>← [[Alpha-Synuclein_Aggregation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Cascade]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Frontotemporal_Dementia]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mitophagy]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Rapamycin]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyotrophic_Lateral_Sclerosis]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Spermidine]] (supplement)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Exercise]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Parkinsons_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Caloric_Restriction]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Intermittent_Fasting]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_Aggregation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Huntingtons_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Neurodegenerative Diseases</h3>
<ul>
<li>→ [[Alzheimer's Disease]] (condition) - <em>Lysosomal dysfunction</em></li>
<li>→ [[Parkinson's Disease]] (condition) - <em>Mitophagy defects</em></li>
<li>→ [[Huntington's Disease]] (condition) - <em>Cargo recognition impaired</em></li>
<li>→ [[Amyotrophic Lateral Sclerosis]] (condition) - <em>Autophagy gene mutations</em></li>
<li>→ [[Frontotemporal Dementia]] (condition) - <em>C9orf72, GRN involvement</em></li>
</ul>
<h3>Related Pathways</h3>
<ul>
<li>→ [[Mitophagy]] (pathway) - <em>Selective mitochondria autophagy</em></li>
<li>→ [[Ubiquitin-Proteasome System]] (pathway) - <em>Complementary degradation</em></li>
<li>→ [[mTOR Signaling]] (pathway) - <em>Master regulator</em></li>
<li>← [[AMPK]] (protein) - <em>Autophagy activator</em></li>
</ul>
<h3>Pathological Cargo</h3>
<ul>
<li>← [[Alpha-Synuclein Aggregation]] (pathway) - <em>Cleared by autophagy</em></li>
<li>← [[Tau Phosphorylation]] (pathway) - <em>Tau degraded by autophagy/CMA</em></li>
<li>← [[Amyloid Cascade]] (pathway) - <em>Aβ cleared by autophagy</em></li>
</ul>
<h3>Interventions</h3>
<ul>
<li>← [[Caloric Restriction]] (intervention) - <em>Potent autophagy inducer</em></li>
<li>← [[Exercise]] (intervention) - <em>Activates AMPK, autophagy</em></li>
<li>← [[Rapamycin]] (drug) - <em>mTOR inhibitor; autophagy inducer</em></li>
<li>← [[Spermidine]] (supplement) - <em>Autophagy enhancer</em></li>
<li>← [[Intermittent Fasting]] (intervention) - <em>Autophagy activation</em></li>
</ul>
<h2>Therapeutic Strategies</h2>
<h3>Autophagy Inducers</h3>
<ul>
<li>Rapamycin/rapalogs (mTOR inhibition)</li>
<li>AMPK activators (metformin, AICAR)</li>
<li>Trehalose (mTOR-independent)</li>
<li>Spermidine</li>
</ul>
<h3>Lysosomal Enhancement</h3>
<ul>
<li>Acidification restoration</li>
<li>Enzyme replacement (LSDs)</li>
<li>Gene therapy for lysosomal enzymes</li>
</ul>
<h3>Substrate Reduction</h3>
<ul>
<li>Reduce toxic protein production</li>
<li>Antisense oligonucleotides</li>
<li>Small molecule aggregation inhibitors</li>
</ul>
<h3>Lifestyle</h3>
<ul>
<li>Caloric restriction mimetics</li>
<li>Exercise prescription</li>
<li>Intermittent fasting protocols</li>
<li>Time-restricted eating</li>
</ul>
<h2>Biomarkers</h2>
<h3>Autophagy Markers</h3>
<ul>
<li>LC3-II/LC3-I ratio</li>
<li>p62/SQSTM1 levels</li>
<li>Autophagy flux assays</li>
</ul>
<h3>Lysosomal Markers</h3>
<ul>
<li>Cathepsin activity</li>
<li>LAMP1/LAMP2 levels</li>
<li>Lysosomal pH</li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Review</strong>: Menzies, F.M., et al. (2017). &quot;Autophagy and neurodegeneration.&quot; <em>Molecular Cell</em>.</li>
<li><strong>Parkinson's</strong>: Nguyen, M., et al. (2019). &quot;Autophagy and Parkinson's disease.&quot; <em>Journal of Parkinson's Disease</em>.</li>
<li><strong>Therapeutics</strong>: Rubinsztein, D.C., et al. (2015). &quot;Autophagy modulation as a potential therapeutic target.&quot; <em>Nature Reviews Drug Discovery</em>.</li>
</ol>

{% endraw %}